Sector: Pharmaceuticals & Biotechnology

Small Cap

Beta Drugs Share Price

BETA

₹2,361.20

-157.70(-6.26%)

7th Aug 2026 | 3:28 PM

NSE : BETA

Open Free Demat Account

Beta Drugs Performance

Price Movement

₹2361.20

₹2306.00

₹2600.00

↘ Today's Low↗ Today's High

1 Year Performance

₹2361.20

₹990.10

₹2674.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹2,600.00

Low₹2,306.00

Open at₹2,539.90

Prev Close₹2,518.90

Volumes99.55 K

Avg Price₹2,403.02

Lower Circuit₹2,015.20

Upper Circuit₹3,022.60

Historical Performance

3M High₹2,674.00

3M Low₹1,171.10

1 Yr High₹2,674.00

1 Yr Low₹990.10

3 Yr High₹2,674.00

3 Yr Low₹763.19

5 Yr High₹2,674.00

5 Yr Low₹303.81

Summary

As of 10-08-2026 04:26, Beta Drugs Ltd. share price today is ₹0, with a change of ₹-2518.90 (-100.00%) from the previous close of ₹2518.9. The stock opened at ₹2539.9 and traded between ₹2306 and ₹2600, with a total traded volume of 99552 shares. The company has a market capitalization of ₹2614.2 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹2674 and ₹990.1, respectively.

Beta Drugs Ltd. valuation metrics include a P/E ratio of 57.3, EPS of ₹40.92, and book value of ₹10.70. Profitability indicators show ROE of 16.94%. Beta Drugs Ltd. has reported revenue of ₹410.17 Cr and net profit of ₹45.59 Cr.

Beta Drugs Ltd. technical indicators include Day RSI at 65.66, Day MFI at 73.35, Day ADX at 33.51. Additional indicators include Commodity Channel Index (CCI) at 181.7 and Williams %R at -25.78. Momentum indicators show Day MACD at 90.74, Day MACD Signal Line at 91.66, DayATR at 140.58. Rate of Change indicators for Beta Drugs Ltd. include ROC125 at 77.3 and ROC21 at 26.07.

Exponential moving averages include EMA5 at ₹2388, EMA10 at ₹2337, EMA12 at ₹2324.9, EMA20 at ₹2276.8, EMA26 at ₹2234.2, EMA50 at ₹2057, EMA100 at ₹1832.9, EMA200 at ₹1704.1. Simple moving averages include SMA5 at ₹2367.1, SMA10 at ₹2292.8, SMA20 at ₹2312.9, SMA30 at ₹2251.5, SMA50 at ₹2025.8, SMA100 at ₹1657.6, SMA150 at ₹1562.3, SMA200 at ₹1594.2.

Support levels for Beta Drugs are placed at First Support ₹2428.53, Second Support ₹2338.17, Third Support ₹2277.43. Resistance levels are seen at First Resistance ₹2579.63, Second Resistance ₹2640.37, Third Resistance ₹2730.73. Beta Drugs Ltd. shareholding pattern shows promoter holding at 59.1%, FII holding at 1.02%, DII holding at 0%, public holding at 33.65%.

Beta Drugs Fundamentals

Market Cap

Above industry Median

2,614.20 Cr.

PE Ratio (TTM)

High in industry

57.30

Dividend Yield

Net Profit TTM

45.59

Net Profit Growth

45.59

PEG Ratio

ROE

21% decr over last year

16.94

Operating Revenue TTM

410.17

Operating Revenue Growth

Book Value

High in industry

10.70

MFI

MFI Overbought

73.35

RSI

RSI is mid-range

65.66

EPS (TTM)

40.92

Debt to Equity

0.60

Face Value

Operating Profit Margin Qtr.

19.11

Operating Profit Qtr.

27.37

Net Profit Qtr.

15.80

Operating Revenue Qtr.

125.55

PB Ratio

10.70

Beta Drugs Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Revenue	55.83	54.35	50.28	54.48	66.32
Operating Expense	45.67	44.59	43.73	49.75	58.82
Operating Profit	10.16	9.76	6.55	4.73	7.51
Depreciation	2.48	2.74	2.51	2.38	2.04
Interest	1.60	2.87	3.17	2.97	2.79
Tax	2	1.73	0.12	0.61	1.42
Net Profit	5.93	5.33	3.25	1.51	4.23

Beta Drugs Technicals

Beta Drugs Ltd. EMA & SMA

₹2361.20

-5.70 (-0.24%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹2388

Day EMA10 ₹2337

Day EMA12 ₹2324.9

Day EMA20 ₹2276.8

Day EMA26 ₹2234.2

Day EMA50 ₹2057

Day EMA100 ₹1832.9

Day EMA200 ₹1704.1

Beta Drugs Support and Resistance

Resistance

First Resistance₹2579.63

Second Resistance₹2640.37

Third Resistance₹2730.73

Support

First Support₹2428.53

Second Support₹2338.17

Third Support₹2277.43

Technical Indicators

Day RSI65.66

Day MFI73.35

Day ADX33.51

Day Commodity Channel Index181.70

William-25.78

Day MACD90.74

Day MACD Signal Line91.66

Day ATR140.58

Day ROC12577.30

Day ROC2126.07

Beta Drugs Shareholding Pattern

Held By	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	66.7	66.7	66.7	64.9	64.6	59.1
FII	0.9	0.9	0.9	1.1	1.2	1
DII	0.2	0.3	0.3	1.9	2.1	6.2
Public	32.2	32.1	32.1	32.1	32	33.6

Beta Drugs Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	28.45 K	66.08 K	43.06%
Week	13.66 K	30.92 K	44.16%
1 Month	18.95 K	61.47 K	30.82%
6 Month	12.52 K	31.1 K	40.24%

Beta Drugs SWOT Analysis

Strengths27

Weakness12

Opportunity1

Threats1

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Expensive Rockets (DVM)

Relative Outperformance versus Industry over 1 Month

Stocks gaining versus previous close, open price and RSI

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Growth in Net Profit with increasing Profit Margin (QoQ)

Increasing Revenue every quarter for the past 2 quarters

Increasing profits every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

Stock gained more than 20% in one month

Highest Recovery from 52 Week Low

RSI indicating price strength

High Volume, High Gain

Top Gainers

High Volume, High Gain

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Beta Drugs Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Beta Drugs Stock Comparison

Financials	Bio Medica Laboratories Ltd.	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.
Price (₹)	₹145	₹574.90	₹5.07	₹107	₹166.15	₹14.61
% Change	-3.37%	6.24%	0.60%	0.00%	-2.00%	2.81%
Revenue TTM (₹ Cr)	-	-	₹69.99	-	₹291.17	₹174.18
Net Profit TTM (₹ Cr)	-	-	₹-176.47	-	₹14.68	₹29.06
PE TTM	11.60	-	-0.20	12.50	44.80	26.00
1 Year Return	7.95	38.05	404	-16.41	34.56	56.15
ROCE	34.19	3.56	-56.37	-	-	17.36

Similar Stocks

MEDISTEP

Medistep Healthcare Ltd.

₹ 20.00

+0.00%

INFLUX

Influx Healthtech Ltd.

₹ 285.00

-2.31%

MEDIORG

Medicamen Organics Ltd.

₹ 27.05

+0.19%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 523.00

+0.58%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 64.59

+4.99%

SIGACHI

Sigachi Industries Ltd.

₹ 25.40

-1.55%

WINDLAS

Windlas Biotech Ltd.

₹ 879.00

+0.60%

VINEETLAB

Vineet Laboratories Ltd.

₹ 37.00

-4.39%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 503.00

-1.58%

ZIMLAB

Zim Laboratories Ltd.

₹ 113.00

-1.87%

MEDICO

Medico Remedies Ltd.

₹ 46.30

-2.98%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 191.65

-1.55%

LASA

Lasa Supergenerics Ltd.

₹ 8.00

+1.91%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 324.00

-1.76%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 330.00

+0.24%

ORTINGLOBE

Ortin Global Ltd.

₹ 15.15

-0.33%

BROOKS

Brooks Laboratories Ltd.

₹ 60.00

-0.08%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2670.00

-0.70%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 285.00

+0.16%

ALPA

Alpa Laboratories Ltd.

₹ 68.10

-2.67%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 378.95

+6.09%

NECLIFE

Nectar Lifesciences Ltd.

₹ 10.58

+0.76%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 27.19

+0.67%

INDOCO

Indoco Remedies Ltd.

₹ 221.40

-0.19%

FAQ's on BETA

What is the Market Capitalization of Beta Drugs Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Beta Drugs Ltd. is approximately ₹ 2614.2 Cr.

What are the PE and PB ratios for Beta Drugs Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Beta Drugs Ltd. is 57.3, and the Price-to-Book (PB) ratio is 10.7.

What is the 52-Week High and Low for Beta Drugs Ltd.?

Over the past 52 weeks, the highest price reached by Beta Drugs Ltd. shares was ₹ 2674, and the lowest price was ₹ 990.1.

Who are the major shareholders of Beta Drugs Ltd.?

Significant shareholdings in Beta Drugs Ltd. typically include entities such as:

Promoter
Public
Other Institutions
FII

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Beta Drugs Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Beta Drugs Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.